December did not start well for the market, with all the major indices in the red. Will the theories urging caution against ...

No one wants to buy Big Pharma's lifesaving drugs, they are forced to by disease. But they are grateful to the researchers who make survival possible.

America wants to reduce its reliance on Chinese supply chains, since it remains in a trade war that is only temporarily on ...

This small ASX-listed Aussie company operates in a high stakes arena and has caught the eye of the US. They’ve just made ...

Pharmaceutical exports are expected to continue on a healthy trajectory over the next few years with products worth over $250 ...

CDMO-linked chemical makers are pulling ahead as tariff shocks, Chinese oversupply, and weak global demand hit the broader ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line.

In addition, Indian API (Active Pharmaceutical Ingredient) manufacturers such as Laurus Labs, Divi’s Labs, Granules India and ...

While much of the narrative centres on the surge in pharma exports to the US earlier this year, Grant Thornton’s Peter Vale ...

Irish Medtech Awards 2025 winners include West Pharmaceutical Services, Palliare, CergenX, Alcon Ireland and Stryker.

Tiziana Life Sciences has pointed to increased Big Pharma interest in the IL-6 pathway as justification for its ...

Discover Nuvama’s top 7 pharma stock picks with up to 33% upside; check out the latest targets and opportunities now.